Skip to main content
Quest Diagnostics

Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic

Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic

Authors: Laffin LJ, Kaufman HW, Chen Z, Niles JK, Arellano AR, Bare LA, Hazen SL

Citation: Circulation. 2021 Dec 6. doi: 10.1161/CIRCULATIONAHA.121.057075. Online ahead of print.

Medical Specialties: Cardiovascular disease, Endocrinology, Cardiology, Infectious Disease, COVID-19

Download key summary

Related content

Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Conference Presentation
SARS-CoV-2 mRNA Vaccination Affects Antibody and Cellular Immune Responses After B-Cell Depletion Therapies
On-Demand Webinar
Combating A Silent Killer: An Evidence-Based Update on the Treatment of Hypertension
Publication
New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.